PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTS
May 1, 2011, 00:00
10.1016/j.jval.2011.02.866
https://www.valueinhealthjournal.com/article/S1098-3015(11)01005-9/fulltext
Title :
PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01005-9&doi=10.1016/j.jval.2011.02.866
First page :
A156
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
334